Health

Health
If you tested positive and the contact tracer never called, here's why
Swamped by thousands of calls a day, contact tracing programs have been forced to adapt. Even though they can't call everyone, experts say it's too early to give up on this pillar of disease control.
Omicron continues pain for event businesses in MN, still not back to normal
The live event and hospitality industries have been hit extremely hard by the COVID-19 pandemic. But they say they have been, for the most part, left out of the financial aid many others have received.
A doctor answers questions about COVID-19 immunity, additional boosters and more
What do we know about the sister variant of omicron? Does someone recovered from COVID-19 have immunity for 90 days? Will we have to get another booster? These questions and more, answered by Mayo Clinic’s Dr. Melanie Swift.
Biden: Child credit money is available via tax returns
The Biden administration wants families with children to know that there is roughly $193 billion waiting for them — all they need to do is file their taxes to claim it.
How evictions can have lasting impacts on health, housing and poverty
Evictions have increased in Minnesota since the moratorium began to phase out in 2021. That can have yearslong repercussions on people’s mental and physical health, educational outcomes and more. Host Angela Davis talks with two researchers about the lasting impacts of evictions.
Paying bills or buying masks: Simple living with COVID is hitting some Americans hard
As the human toll of the coronavirus continues to mount, so does the cost that comes from living during a pandemic. For some, it means choosing between paying bills or buying masks just to stay safe.
Governors in 4 states plan for end to school mask mandates
The decisions in Connecticut, Delaware, New Jersey and Oregon were announced Monday as state and local governments grapple with which COVID-19 restrictions to jettison and which ones to keep in place. 
Why remdesivir, a highly effective treatment, is a last resort for providers
The antiviral infusion was just revived as an early treatment for COVID patients. But the drug is relatively expensive and hard to administer, relegating it what some are calling "stopgap" status.